Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Int J Epidemiol. 2016 Sep 26;46(3):796–796i. doi: 10.1093/ije/dyw152

Table 3B.

Comparison of SDRNT1BIO participants with national Scottish population with Type 1 Diabetes (categorical variables)

Characteristic Type 1 Bioresource participants (N=6127)
N, percent (SE)
National T1DM population (N=24552)
N, percent (SE)
Female sex 2696, 44.0 (0.009) 10718, 43.7 (0.002)
Diabetes duration ≥ 5 y 5440, 88.8 (0.002) 21793, 88.8 (0.000)
Diabetes diagnosed at age 50 y 308, 5.03 (0.016) 892, 3.6 (0.004)
Known MODY 29, 0.47 (0.016)          N/A
Known LADA 4, 0.07 (0.016)          N/A
SIMD quintile
  1 (most deprived) 956, 15.8 (0.014) 4750 , 20.0 (0.003)
  2 1021, 16.8 (0.014) 4807 , 20.3 (0.003)
  3 1158, 19.1 (0.013) 4932, 20.8 (0.003)
  4 1369, 22.6 (0.013) 4723, 19.9 (0.003)
  5 (least deprived) 1562, 25.8 (0.012) 4515, 19.0 (0.003)
History of diabetes related complications
  Any retinopathy ever 4681, 77.4 (0.004) 17862, 77.1 (0.001)
  Retinopathy at most recent screening 3832, 63.4 (0.006) 12777 , 55.1 (0.002)
  Cardiovascular disease admission 473, 7.7 (0.015) 2212, 9.0 (0.004)
  Ever received dialysis 73, 1.2 (0.016) 363, 1.5 (0.004)
Albuminuric status
  Normoalbuminuric 4605, 88.6 (0.002) 17578, 81.4 (0.001)
  Microalbuminuric 449, 8.6 (0.018) 3196, 14.8 (0.004)
  Macroalbuminuric 141, 2.7 (0.019) 823, 3.8 (0.004)
Albuminuric status based on SDRNT1BIO samples (≥ 1 ACR reading) 5839, 95.3 (0.00)

SE, standard error of mean; ACR, urine albumin to creatinine ratio; y, years; N/A, not applicable.